These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 10576652

  • 1. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
    Kiaris H, Schally AV, Nagy A, Sun B, Armatis P, Szepeshazi K.
    Br J Cancer; 1999 Nov; 81(6):966-71. PubMed ID: 10576652
    [Abstract] [Full Text] [Related]

  • 2. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB, Keller G, Schally AV, Halmos G, Hammann B, Nagy A.
    Clin Cancer Res; 2005 Mar 15; 11(6):2408-15. PubMed ID: 15788692
    [Abstract] [Full Text] [Related]

  • 3. Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.
    Keller G, Schally AV, Nagy A, Halmos G, Baker B, Engel JB.
    Cancer; 2005 Nov 15; 104(10):2266-74. PubMed ID: 16211544
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
    Kiaris H, Schally AV, Sun B, Armatis P, Groot K.
    Oncogene; 1999 Nov 25; 18(50):7168-73. PubMed ID: 10597318
    [Abstract] [Full Text] [Related]

  • 5. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ.
    Br J Cancer; 1994 Nov 25; 70(5):886-92. PubMed ID: 7947094
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K.
    Cancer Res; 1994 Nov 15; 54(22):5895-901. PubMed ID: 7954420
    [Abstract] [Full Text] [Related]

  • 7. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, Avis I, Cuttitta F, Mulshine JL, Moody TW.
    Cancer Res; 1991 Apr 01; 51(7):1798-802. PubMed ID: 1848479
    [Abstract] [Full Text] [Related]

  • 8. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
    Thomas F, Arvelo F, Antoine E, Jacrot M, Poupon MF.
    Cancer Res; 1992 Sep 15; 52(18):4872-7. PubMed ID: 1325285
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
    Chatzistamou I, Schally AV, Sun B, Armatis P, Szepeshazi K.
    Br J Cancer; 2000 Oct 15; 83(7):906-13. PubMed ID: 10970693
    [Abstract] [Full Text] [Related]

  • 10. Effective treatment of H838 human non-small cell lung carcinoma with a targeted cytotoxic somatostatin analog, AN-238.
    Szereday Z, Schally AV, Szepeshazi K, Bajo AM, Hebert F, Halmos G, Nagy A.
    Int J Oncol; 2003 May 15; 22(5):1141-6. PubMed ID: 12684683
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.
    Szepeshazi K, Schally AV, Nagy A, Wagner BW, Bajo AM, Halmos G.
    Cancer; 2003 Oct 01; 98(7):1401-10. PubMed ID: 14508826
    [Abstract] [Full Text] [Related]

  • 12. A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice.
    Kiaris H, Schally AV, Nagy A, Szepeshazi K, Hebert F, Halmos G.
    Eur J Cancer; 2001 Mar 01; 37(5):620-8. PubMed ID: 11290438
    [Abstract] [Full Text] [Related]

  • 13. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
    Szepeshazi K, Schally AV, Treszl A, Seitz S, Halmos G.
    Anticancer Drugs; 2008 Apr 01; 19(4):349-58. PubMed ID: 18454045
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203
    [Abstract] [Full Text] [Related]

  • 15. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
    Koppán M, Halmos G, Arencibia JM, Lamharzi N, Schally AV.
    Cancer; 1998 Oct 01; 83(7):1335-43. PubMed ID: 9762934
    [Abstract] [Full Text] [Related]

  • 16. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
    Koppan M, Nagy A, Schally AV, Arencibia JM, Plonowski A, Halmos G.
    Cancer Res; 1998 Sep 15; 58(18):4132-7. PubMed ID: 9751625
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A, Schally AV, Nagy A, Sun B, Szepeshazi K.
    Cancer Res; 1999 Apr 15; 59(8):1947-53. PubMed ID: 10213505
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A, Schally AV, Nagy A, Kiaris H, Hebert F, Halmos G.
    Cancer Res; 2000 Jun 01; 60(11):2996-3001. PubMed ID: 10850448
    [Abstract] [Full Text] [Related]

  • 19. Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.
    Stangelberger A, Schally AV, Letsch M, Szepeshazi K, Nagy A, Halmos G, Kanashiro CA, Corey E, Vessella R.
    Int J Cancer; 2006 Jan 01; 118(1):222-9. PubMed ID: 16003723
    [Abstract] [Full Text] [Related]

  • 20. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
    Kado-Fong H, Malfroy B.
    J Cell Biochem; 1989 Aug 01; 40(4):431-7. PubMed ID: 2550492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.